RNAC Operating Cash Flow (Statement)
Cartesian Therapeutics Inc · Operating Cash Flow (Statement)
RNAC Operating Cash Flow (Statement)
Latest reported-$20.63Mperiod ending
RNAC Quarterly Cash from Operations (-$4.90M → -$20.63M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
RNAC operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -20,626,000 | |
| -22,135,000 | |
| -17,712,000 | |
| -15,600,000 | |
| -17,521,000 | |
| -23,108,000 | |
| -7,002,000 | |
| 13,691,000 | |
| -14,446,000 | |
| -15,917,000 | |
| -23,286,000 | |
| -9,215,000 | |
| -9,895,000 | |
| -8,765,000 | |
| -11,849,000 | |
| 4,353,000 | |
| -12,271,000 | |
| -11,864,000 | |
| -31,460,000 | |
| -10,746,000 | |
| -6,043,000 | |
| -12,133,000 | |
| -7,250,000 | |
| 65,637,000 | |
| -11,808,000 | |
| -11,698,000 | |
| -12,876,000 | |
| -11,122,000 | |
| -7,197,000 | |
| -20,240,000 | |
| -12,748,000 | |
| -16,031,000 | |
| -16,973,000 | |
| -13,409,000 | |
| -12,672,000 | |
| -15,435,000 | |
| -8,614,000 | |
| -15,316,000 | |
| 1,556,000 | |
| -5,466,000 | |
| -5,607,000 | |
| -10,166,000 | |
| -7,640,000 | |
| -5,612,000 | |
| -4,313,000 | |
| -4,898,000 |